This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Request for Proposals
The Agency for Healthcare Research and Quality is accepting proposals for
Small Business Innovative Research Program, Phase I.
Solicitation Number AHRQ-01-0014; 100-percent Small Business Set Aside under
SIC Code 7379-Offers are solicited from small business concerns only.
Proposal Due: March 19, 2001, 3:00 P.M., local prevailing time
Contracting Office: Agency for Healthcare Research and Quality: Division of
Contracts Management, 2101 East Jefferson Street, Suite 601, Rockville, MD
20852; fax (301) 443-7523.
The mission of the Agency for Healthcare Research and Quality (AHRQ) is to
enhance the quality, appropriateness, and effectiveness of health services and
to provide access to such services. AHRQ applies broad-based scientific research
designed to (1) improve clinical practice; (2) improve the health care system's
ability to provide access to and deliver high-quality, high-value health care;
and (3) provide policymakers with the ability to assess the impact of system
changes on outcomes, quality, access, cost, and use of health services.
The synopsis for this requirement was published in the Commerce Business
Daily on January 12, 2001. The solicitation was issued on January 31, 2001.
Full text can be downloaded from the AHRQ Web site. Select to access Downloading
Information. Printed copies are also available by writing to the above
address. No telephone requests for the RFP will be accepted.
It is anticipated that multiple contracts will be awarded for the Phase I
period. It is anticipated that this contract will be awarded in April 2001.
This solicitation invites proposals in the following area:
Topic: Developing Tools to Enhance Quality and Patient Safety Through
The Institute of Medicine recently estimated that 44,000-98,000 people die in
American hospitals each year because of medical errors. Many of these errors
could be prevented through use of modern information technology. Technology
applications can also be used to:
- Provide evidence-based decision support to providers at the time and
- Provide evidence-based information to patients.
- Enhance shared decisionmaking and self-care.
- Increase access to care for patients living in remote or underserved
- Facilitate sharing of important clinical data among providers in disparate
- Improve the overall quality of care.
Examples of such technology include biomedical databases, electronic medical
records, computerized order entry, handheld wireless computers, Internet
applications, and computerized decision-support systems.
The Agency seeks Phase I SBIR proposals to:
- Develop informatics tools that enhance patient safety by reducing medical
errors and injuries.
- Develop Internet or other computer applications that enhance
patient-provider communication and shared decision-making.
- Develop applications that allow providers to share medical records and
other medical information with their patients.
- Develop handheld or other portable device applications for patients and
Proposals must address how the use of these technologies can improve quality
of care and patient safety.
In Phase I, investigators should propose an approach or combination of
approaches for identifying factors important in the development of these tools
and devices. Potential approaches may include:
- Patient and provider focus groups.
- Comprehensive literature reviews.
- Secondary data analysis.
- Other techniques appropriate for Phase I contracts.
The contractor will be expected to develop prototype devices and
interventions, such as Web-based technologies that interactively link patients
with their health care providers and health care systems.
In Phase II, the investigators will be expected to expand on the prototype
developed during Phase I and begin implementation and testing of the prototype
devices and interventions. Phase II must include an assessment of the
intervention's impact on important measurable outcomes such as a reduction in
medication errors, increase in compliance with recommended treatment guidelines,
etc. Beta testing is to be completed at the end of the Phase II period. The
final product should be applicable and adaptable to a variety of health care
populations, conditions, and settings.
Shift-click from this Web page: Your browser may support downloading
the RFP and Appendixes from this Web page. To download the RFP from this Web
page, click on the following links with the right mouse button and select "Save
Link As" (Netscape) or "Save Target As" (Internet Explorer). The RFP is
available as WordPerfect® and PDF Files:
PDF Files require the Adobe® Acrobat® Reader™, which you can download free
Current as of January 2001